» Articles » PMID: 6308046

High Affinity Esterification of Eicosanoid Precursor Fatty Acids by Platelets

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1983 Jul 1
PMID 6308046
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

We have examined the relative rates of uptake of several fatty acids into washed, human platelets by measuring incorporation into cellular phospholipids. In the presence of 15 microM fatty acid-free albumin and with radioactive fatty acid concentrations of 5-500 nM, esterification into phospholipid was linear with time and platelet concentration and saturable with respect to fatty acid concentration. Two distinct classes of uptake rate were observed. Arachidonate and 5,8,11,14,17-eicosapentaenoate exhibited high affinity, relatively rapid incorporation into platelet phospholipids at pH 6.5: apparent Michaelis constant (Km) = 30 nM, apparent maximum velocity (Vmax) = 28 pmol/min per 10(9) platelets. Two other eicosanoid precursors, 5,8,11-eicosatrienoate and 8,11,14-eicosatrienoate, exhibited the same Vmax, but Km of 85 and 60 nM, respectively. Under the same conditions, stearate, oleate, and linoleate were incorporated into phospholipids much less efficiently (Vmax approximately 8 pmol/10(9) cells per min, apparent Km greater than or equal to 170 nM). Qualitatively similar results were found at pH 7.4. Uptake of radiolabeled, rapid-uptake fatty acids was not diminished by the presence of excess, unlabeled, slow-uptake fatty acids. Thus, the specificity of this esterification system resembles that of the arachidonate-specific, long-chain acyl-CoA synthetase present in platelets. It may represent the expression in vivo of the synthetase, although the apparent affinity of the synthetase for fatty acid is much less. This esterification system probably represents the physiologic mechanism for platelet arachidonate uptake, whereby arachidonate is collected from plasma, despite the fact that its concentration is considerably lower than that of other plasma fatty acids.

Citing Articles

The influence of placental metabolism on fatty acid transfer to the fetus.

Perazzolo S, Hirschmugl B, Wadsack C, Desoye G, Lewis R, Sengers B J Lipid Res. 2016; 58(2):443-454.

PMID: 27913585 PMC: 5282960. DOI: 10.1194/jlr.P072355.


Nutritional properties of dietary omega-3-enriched phospholipids.

Murru E, Banni S, Carta G Biomed Res Int. 2013; 2013:965417.

PMID: 23984423 PMC: 3747496. DOI: 10.1155/2013/965417.


Nutritional modifiers of aging brain function: use of uridine and other phosphatide precursors to increase formation of brain synapses.

Wurtman R, Cansev M, Sakamoto T, Ulus I Nutr Rev. 2010; 68 Suppl 2:S88-101.

PMID: 21091953 PMC: 3062998. DOI: 10.1111/j.1753-4887.2010.00344.x.


Synapse formation is enhanced by oral administration of uridine and DHA, the circulating precursors of brain phosphatides.

Wurtman R, Cansev M, Ulus I J Nutr Health Aging. 2009; 13(3):189-97.

PMID: 19262950 DOI: 10.1007/s12603-009-0056-3.


Oral administration of circulating precursors for membrane phosphatides can promote the synthesis of new brain synapses.

Cansev M, Wurtman R, Sakamoto T, Ulus I Alzheimers Dement. 2008; 4(1 Suppl 1):S153-68.

PMID: 18631994 PMC: 2344157. DOI: 10.1016/j.jalz.2007.10.005.


References
1.
Cohen P, Derksen A, van den Bosch H . Pathways of fatty acid metabolism in human platelets. J Clin Invest. 1970; 49(1):128-39. PMC: 322451. DOI: 10.1172/JCI106211. View

2.
Spector A, HOAK J, WARNER E, Fry G . Utilization of long-chain free fatty acids by human platelets. J Clin Invest. 1970; 49(8):1489-96. PMC: 322628. DOI: 10.1172/JCI106366. View

3.
Baenziger N, MAJERUS P . Isolation of human platelets and platelet surface membranes. Methods Enzymol. 1974; 31:149-55. DOI: 10.1016/0076-6879(74)31015-4. View

4.
Spector A . Fatty acid binding to plasma albumin. J Lipid Res. 1975; 16(3):165-79. View

5.
Hagenfeldt L . Turnover of individual free fatty acids in man. Fed Proc. 1975; 34(13):2246-9. View